Introduction
Obstructive Sleep Apnea Syndrome (OSAS) affects approximately 4% of middle-aged men and 2% of middle-aged women [
1], with around 10% of hypertensive patients having coexisting OSAS [
2]. The well-documented complications of hypertension and cardiovascular disease in patients with OSAS emphasizes the importance of timely intervention [
1,
3]. Therapeutic interventions, including the use of continuous positive airway pressure (CPAP), are crucial for managing OSAS, with CPAP being a non-invasive and easily implementable option [
4,
5]. However, the initial stages of CPAP therapy can pose challenges for patients due to the adjustment process [
4].
Given the prevalence of OSAS among hypertensive patients and the known benefits of CPAP therapy, it is essential to explore the impact of CPAP on blood pressure control in this population. This case report highlights a significant improvement in blood pressure following the introduction of CPAP in OSAS patients with hypertension. Additionally, providing individualized data to patients in a clinical setting may enhance their compliance with CPAP treatment, ultimately improving their overall health outcomes.
Case Report
A 51-year-old male presented with a history of hypertension and a prior diagnosis of OSAS. He had a weight of 80 kg, a height of 172 cm, and a BMI of 27 kg/m². The patient had smoked cigarettes for ten years but had been a non-smoker for 17 years. He consumed alcohol socially. OSAS was diagnosed at approximately 30 years old with an Apnea-Hypopnea Index (AHI) of 34, indicating a severe form of OSAS. However, no treatment, such as CPAP, had been administered at the time. The patient was diagnosed with hypertension during a health checkup at age 50 and initiated treatment with anti-hypertensive drugs (Exforge®; Amlodipine 5 mg/day; Valsartan 80 mg/day). Despite medication, his blood pressure remained elevated, especially in the early morning. He reported morning headaches and daytime sleepiness, prompting consultation for OSAS. Polysomnography confirmed the diagnosis of OSAS, and CPAP therapy (AEONMED AS100A-RT) was initiated in January 2023 with auto-CPAP (pressure settings: 3-12 cm H2O).
The patient diligently recorded his blood pressure before and after CPAP treatment. Blood pressure measurements were recorded 77 times immediately before and 93 times immediately after CPAP treatment. In addition, pre-bedtime blood pressure measurements before and after CPAP treatment were analyzed (53 and 89 measurements, respectively). Before CPAP treatment, the average morning blood pressure was 146/96 mmHg, higher than the average bedtime blood pressure of 128/77 mmHg [Fig.1]. After CPAP therapy, the average morning blood pressure decreased significantly to 130/86 mmHg, representing a 15 mmHg reduction in systolic pressure (p<0.0001) [Fig.2,3]. Similarly, bedtime blood pressure also improved compared to pre-CPAP therapy [Table 1]. Additionally, the patient reported improvement in morning headaches and daytime sleepiness. The CPAP device recorded a simple AHI of 4.0, indicating alleviation of symptoms due to marked improvement in OSAS.
Discussion
The prevalence of OSAS among hypertensive patients emphasizes the importance of effective management strategies for both conditions [
1,
2]. CPAP therapy has emerged as a cornerstone in the treatment of OSAS due to its efficacy and non-invasive nature [
3,
4]. Our case demonstrates a significant reduction in blood pressure following the initiation of CPAP therapy in a patient with coexisting OSAS and hypertension. This finding aligns with previous studies indicating the beneficial effects of CPAP on blood pressure control in hypertensive patients with OSAS [
5,
6]. Moreover, the improvement in morning headaches and daytime sleepiness observed in our patient highlights the broader impact of CPAP therapy on symptom management and quality of life [
7]. Individualized data given to patients regarding the effects of CPAP treatment may contribute to enhanced compliance and long-term adherence.
While our case provides valuable insights into the therapeutic potential of CPAP in OSAS patients with hypertension, further research is warranted to elucidate the mechanisms underlying the observed blood pressure reduction and to assess the long-term cardiovascular outcomes associated with CPAP therapy in this population.
Conclusion
Our case emphasizes the significant role of CPAP therapy in improving blood pressure control and alleviating symptoms in patients with OSAS and hypertension. The successful management of hypertension through CPAP therapy highlights the importance of comprehensive treatment approaches in individuals with co-existing sleep disorders and cardiovascular conditions. Further research is needed to elucidate the long-term effects of CPAP therapy on cardiovascular outcomes and to optimize the management of OSAS in hypertensive patients.
Contributors: YH drafted the manuscript. KY, SZ and SS critically reviewed and revised the manuscript. YH will act as a study guarantor. All authors approved the final version of this manuscript and are responsible for all aspects of this study.
Funding: None; Competing interests: None stated.
Acknowledgements: We would like to thank Editage (www.editage.com) for the English language editing.
References
- Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046-1053.
- Kario K. Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control. Hypertens Res. 2009;32(7):537-541.
- Chang JL, Goldberg AN, Alt JA, Mohammed A, Ashbrook L, Auckley D, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2023;13(7):1061-1482.
- Bock JM, Needham KA, Gregory DA, Ekono MM, Emerson M Wickwire EM, et al. Continuous positive airway pressure adherence and treatment cost in patients with obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc Innov Qual Outcomes. 2022;6(2):166-175.
- Duong-Quy S, Nguyen-Huu H, Hoang-Chau-Bao D, Tran-Duc S, Nguyen-Thi-Hong L, Nguyen-Duy T, et al. Personalized medicine and obstructive sleep apnea. J Pers Med. 2022;12(12):2034.
- Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-423.
- Bakker JP, Weaver TE, Parthasarathy S, Aloia MS. Adherence to CPAP: what should we be aiming for, and how can we get there? Chest. 2019;155(6):1272-1287.